ANCA-associated systemic vasculitis in Japan: Clinical features and prognostic changes

Clinical and Experimental Nephrology

Volumn 16, Issue 4, 2012, Pages 580-588

  Yamagata, Kunihiro ^a,b   Usui, Joichi ^a   Saito, Chie ^a   Yamaguchi, Naoto ^a   Hirayama, Kouichi ^a   Mase, Kaori ^a   Kobayashi, Masaki ^a   Koyama, Akio ^a   Sugiyama, Hitoshi ^b   Nitta, Kosaku ^b   Wada, Takashi ^b   Muso, Eri ^b   Arimura, Yoshihiro ^b   Makino, Hirofumi ^b   Matsuo, Seiichi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Steering Committee for the Japanese   (Japan)

Author keywords

Anti neutrophil cytoplasmic auto antibody (ANCA); Immunosuppression; Prognosis changes; Rapidly progressive glomerulonephritis (RPGN); Vasculitis

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COHORT STUDIES; CREATININE; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865110816     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0598-2     Document Type: Article

References (18)

1. DJ Davies JE Moran JF Niall GB Ryan 1982 Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J Clin Res Ed 285 606 6297657 10.1136/bmj.285.6342.606 1:STN:280:DyaL3s7ivVansA%3D%3D (Pubitemid 12042688)
2. RJ Falk JC Jennette 1988 Anti-neutrophic cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 1651 1657 2453802 10.1056/NEJM198806233182504 1:STN:280:DyaL1c3jt1yhuw%3D%3D
3. C Franssen C Stegeman C Kallenberg R Gans P Jong S Hoornije, et al. 2000 Antipreteinase 3- and antimyeloperoxidase-associated vasculitis Kidney Int 57 2195 2206 10844589 10.1046/j.1523-1755.2000.00080.x 1:CAS:528: DC%2BD3cXkt1CgtL8%3D (Pubitemid 30340718)
4. A Vizjak T Rott M Koselj-Kajtna B Rozman S Kaplan-Pavlovcic D Ferluga 2003 Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity Am J Kidney Dis 41 539 549 12612976 10.1053/ajkd.2003.50142 (Pubitemid 36278370)
5. HA Hauer IM Bajema HC van Houwelingen F Ferrario LH Noel R Waldherr, et al. 2002 Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups Kidney Int 61 80 89 11786087 10.1046/j.1523-1755.2002.00089.x (Pubitemid 34075133)
6. A Koyama K Yamagata H Makino Y Arimura T Wada K Nitta, et al. 2009 A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity Clin Exp Nephrol 13 633 650 19533266 10.1007/s10157-009-0201-7
7. H Sakai K Kurokawa A Koyama Y Arimura H Kida S Shigematsu, et al. 2002 Clinical Guildeline for rapidly progressive glomerulonephritis in Japan Jap J Nephrol 44 55 82 (Pubitemid 34456622)
8. SL Hogan PH Nachman AS Wilkman JC Jennette RJ Falk 1996 Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis J Am Soc Nephrol 7 23 32 8808106 1:STN:280:DyaK28vgtlyhug%3D%3D (Pubitemid 26067088)
9. M Gayraud L Guillevin P le Toumelin P Cohen F Lhote P Casassus, et al. 2001 Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients Arthritis Rheum 44 666 675 11263782 10.1002/1529-0131(200103)44: 3<666::AID-ANR116>3.0.CO;2-A 1:STN:280:DC%2BD3M7mtlyntw%3D%3D (Pubitemid 32234626)
10. KK Jindal 1999 Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations Kidney Int Suppl 70 S33 S40 10369193 10.1046/j.1523-1755.1999.07005.x 1:STN:280: DyaK1M3psFyltQ%3D%3D
11. AS Fauci P Katz BF Haynes SM Wolff 1979 Cyclophosphamide therapy of severe systemic necrotizing vasculitis N Engl J Med 301 235 238 36563 10.1056/NEJM197908023010503 1:STN:280:DyaE1M7pvFGnsw%3D%3D (Pubitemid 9234482)
12. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev: CD005590 2007.
13. RA de Lind van Wijngaarden HA Hauer R Wolterbeek Jayne G Gaskin N Rasmussen, et al. 2007 Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis J Am Soc Nephrol 18 2189 2197 17596637 10.1681/ASN.2007010066 (Pubitemid 47041084)
14. CJ Day AJ Howie P Nightingale S Shabir D Adu CO Savage, et al. 2010 Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine Am J Kidney Dis 55 250 258 20045237 10.1053/j.ajkd.2009.10.047
15. DR Jayne G Gaskin N Rasmussen D Abramowicz F Ferrario L Guillevin, et al. 2007 Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180 2188 17582159 10.1681/ASN.2007010090 1:CAS:528:DC%2BD2sXotlWnur0%3D (Pubitemid 47041083)
16. D Jayne N Rasmussen K Andrassy P Bacon JW Tervaert J Dadoniene, et al. 2003 A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 36 44 12840090 10.1056/NEJMoa020286 1:CAS:528:DC%2BD3sXltFGku70%3D (Pubitemid 36765101)
17. R Nowack U Gobel P Klooker O Hergesell K Andrassy FJ van der Woude 1999 Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement J Am Soc Nephrol 10 1965 1971 10477149 1:CAS:528:DyaK1MXmtVSmt7o%3D (Pubitemid 29402518)
18. K Hirayama M Kobayashi Y Hashimoto J Usui Y Shimizu A Hirayama, et al. 2004 Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis Am J Kidney Dis 44 57 63 15211438 10.1053/j.ajkd.2004.03.030 1:CAS:528:DC%2BD2cXmt1equ74%3D (Pubitemid 38880927)